Semnur Pharmaceuticals, Inc. (SMNR)

0.4625 0.00 (0.00%) USD  |  OTCM  |  Sep 24, 16:00
More

Semnur Pharmaceuticals Research and Development Expense (Annual) : 2.546M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for SMNR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 2.546M
Date Value
December 31, 2024 1.709M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Scilex Holding Co. 20.71M
ANI Pharmaceuticals, Inc. 51.66M
Corcept Therapeutics, Inc. 254.91M
Veru, Inc. 15.59M
Johnson & Johnson 14.83B